Thomas Klingebiel Selected Research

Laryngeal Edema

1/2012	Home therapy with intravenous human C1-inhibitor in children and adolescents with hereditary angioedema.
9/2009	C1-inhibitor concentrate for individual replacement therapy in patients with severe hereditary angioedema refractory to danazol prophylaxis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thomas Klingebiel Research Topics

Disease

67	Neoplasms (Cancer) 06/2022 - 03/2003
25	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 02/2003
22	Leukemia 12/2020 - 02/2003
17	Sarcoma (Soft Tissue Sarcoma) 01/2022 - 03/2006
14	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 01/2004
13	Neuroblastoma 01/2021 - 03/2003
10	Rhabdomyosarcoma 01/2022 - 04/2003
9	Infections 01/2019 - 04/2003
8	Ewing Sarcoma (Sarcoma, Ewing) 01/2022 - 01/2005
7	Residual Neoplasm 01/2021 - 01/2009
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 11/2011
7	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 11/2004
6	Aspergillosis 06/2014 - 07/2003
5	Synovial Sarcoma (Synovioma) 06/2022 - 01/2017
5	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 04/2010
5	Mycoses (Diseases, Fungus) 01/2019 - 07/2003
4	Neoplasm Metastasis (Metastasis) 10/2016 - 01/2005
4	Osteosarcoma (Osteogenic Sarcoma) 02/2015 - 01/2005
4	Hereditary Angioedemas 01/2012 - 09/2009
4	Hemophilia A (Haemophilia) 07/2010 - 06/2002
3	Alveolar Rhabdomyosarcoma 01/2022 - 04/2003
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 02/2005
3	Juvenile Myelomonocytic Leukemia 01/2021 - 02/2003
3	Hodgkin Disease (Hodgkin's Disease) 10/2018 - 04/2004
3	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2017 - 12/2006
3	Invasive Fungal Infections 03/2013 - 01/2013
2	Brain Neoplasms (Brain Tumor) 01/2021 - 02/2013
2	Virus Diseases (Viral Diseases) 12/2020 - 01/2017
2	Disease Progression 10/2018 - 01/2003
2	Fever (Fevers) 10/2018 - 09/2011
2	Neutropenia 10/2018 - 01/2006
2	Pathologic Complete Response 01/2018 - 04/2004
2	Embryonal Rhabdomyosarcoma 01/2015 - 04/2003
2	Laryngeal Edema 01/2012 - 09/2009
2	Lymphoma (Lymphomas) 01/2012 - 11/2004
2	Necrosis 11/2011 - 11/2010
2	Inflammation (Inflammations) 09/2011 - 09/2003
2	Fatigue 09/2011 - 07/2010
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2008 - 01/2006
2	Cytopenia 03/2007 - 03/2005

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 01/2019 - 09/2003
7	Pharmaceutical PreparationsIBA 01/2022 - 03/2003
6	Vincristine (Oncovin)FDA LinkGeneric 01/2022 - 03/2003
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 03/2003
6	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 09/2005
4	Chimeric Antigen ReceptorsIBA 01/2022 - 09/2017
4	Ifosfamide FDA LinkGeneric 01/2022 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 11/2019 - 08/2015
4	Interleukin-2 (IL2)IBA 10/2018 - 02/2010
4	Busulfan (Busulfex)FDA Link 09/2018 - 09/2003
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 09/2005
3	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 09/2005
3	Dactinomycin (Actinomycin)FDA LinkGeneric 01/2022 - 01/2018
3	SteroidsIBA 01/2018 - 07/2010
3	Antineoplastic Agents (Antineoplastics)IBA 02/2011 - 03/2006
3	Methotrexate (Mexate)FDA LinkGeneric 07/2010 - 02/2005
3	Factor VIII (Coagulation Factor VIII)IBA 08/2009 - 06/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2014
2	AnthracyclinesIBA 01/2021 - 07/2013
2	Cisplatin (Platino)FDA LinkGeneric 03/2020 - 01/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 12/2019 - 06/2014
2	GANT 61IBA 11/2019 - 10/2018
2	Carrier Proteins (Binding Protein)IBA 11/2019 - 09/2010
2	Interleukin-15 (Interleukin 15)IBA 01/2019 - 01/2012
2	interleukin-21 (interleukin 21)IBA 01/2019 - 01/2017
2	TESIBA 01/2019 - 01/2019
2	dinutuximabIBA 10/2018 - 01/2011
2	Melphalan (Alkeran)FDA LinkGeneric 09/2018 - 09/2005
2	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2018 - 07/2013
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 07/2010
2	Peptides (Polypeptides)IBA 01/2018 - 08/2009
2	AntigensIBA 09/2017 - 08/2013
2	InterleukinsIBA 01/2017 - 01/2012
2	Biological ProductsIBA 12/2016 - 06/2015
2	Interferon-gamma (Interferon, gamma)IBA 11/2011 - 02/2010
2	LigandsIBA 11/2010 - 09/2010
2	Neutralizing AntibodiesIBA 08/2009 - 11/2008
2	liposomal amphotericin B FDA Link 01/2006 - 07/2003
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 06/2022
1	Epirubicin (Ellence)FDA LinkGeneric 01/2022
1	entrectinibIBA 02/2021
1	larotrectinibIBA 02/2021

Therapy/Procedure

57	Therapeutics 06/2022 - 04/2003
42	Drug Therapy (Chemotherapy) 06/2022 - 05/2003
40	Stem Cell Transplantation 12/2019 - 01/2003
23	Hematopoietic Stem Cell Transplantation 01/2022 - 12/2006
18	Transplantation 01/2019 - 01/2003
13	Immunotherapy 01/2019 - 05/2004
10	Radiotherapy 06/2022 - 01/2008
7	Induction Chemotherapy 10/2017 - 03/2009
6	Combined Modality Therapy 01/2020 - 01/2005
3	Aftercare (After-Treatment) 01/2022 - 01/2016
3	Combination Drug Therapy (Combination Chemotherapy) 03/2020 - 02/2011
3	Haploidentical Transplantation 06/2014 - 09/2004
3	Homologous Transplantation 08/2013 - 06/2008
2	Consolidation Chemotherapy 01/2021 - 10/2016
2	Operative Surgical Procedures 01/2019 - 01/2019
2	Maintenance Chemotherapy 01/2018 - 09/2005
2	Chemoradiotherapy 11/2016 - 05/2011
2	Neoadjuvant Therapy 01/2015 - 11/2010